D. Moher et al., COMPLETENESS OF REPORTING OF TRIALS PUBLISHED IN LANGUAGES OTHER THANENGLISH - IMPLICATIONS FOR CONDUCT AND REPORTING OF SYSTEMATIC REVIEWS, Lancet, 347(8998), 1996, pp. 363-366
Background Lately, the number of systematic reviews published has incr
eased substantially. Many systematic reviews exclude trials published
in languages other than English. However, there is little empirical ev
idence to support this action. We looked for differences in the comple
teness of reporting between trials published in other languages and th
ose published in English, to see whether the exclusion of trials publi
shed in other languages is justified. Methods We compared completeness
of reporting, design characteristics, and analytical approaches of 13
3 randomised controlled trials (RCTs) published in English between 198
9 and 1994 and 96 published in French, German, Italian, or Spanish dur
ing the same time. RCTs were identified by hand searching of journals
(seven in English and six in the other languages). Findings We found n
o significant differences between trials published in English and othe
r-language trials for any single item in the completeness of reporting
scale (randomisation, double-blinding, withdrawals), or for the overa
ll score (percentage of maximum possible score 51.0% for trials in Eng
lish, 46.2% for trials in other languages, 95% CI for difference -1.1
to 10.5). Other-language trials were more likely than English-language
trials to have adult participants, to use two or more interventions,
and to compare two or more active treatments without an untreated cont
rol group. Trials in other languages were less likely to report a clea
rly prespecified primary outcome or any rationale for sample size esti
mation. Interpretation These results provide evidence for inclusion of
all trial reports, irrespective of the language in which they are pub
lished, in systematic reviews, Their inclusion is likely to increase p
recision and may reduce systematic errors. We hope that our findings w
ill prove useful to those developing guidelines and policies for the c
onduct of reporting of systematic reviews.